title: Auditory neurotoxicity and hepatotoxicity after MSMA (monosodium methanarsenate) high dose oral intake.
authors: Poison Control Centre, Hospital de Clínicas, University of Campinas, São Paulo, Brazil. capitani@fcm.unicamp.br
authors: E M
authors: EM
authors: De Capitani
authors: R J
authors: RJ
authors: Vieira
authors: P R
authors: PR
authors: Madureira
authors: S M
authors: SM
authors: Mello
authors: C S
authors: CS
authors: Kira
authors: P C
authors: PC
authors: Soubhia
authors: A S
authors: AS
authors: Toledo
mesh_terms: D000328:Adult; D000931:Antidotes / Q000627:therapeutic use; D001151:Arsenic / Q000652:urine; D020261:Arsenic Poisoning / Q000473:pathology* / Q000523:psychology*; D001152:Arsenicals; D001299:Audiometry; D001663:Bilirubin / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000473:pathology*; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000175:diagnosis; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008099:Liver / Q000201:enzymology; D008111:Liver Function Tests; D008297:Male; D020258:Neurotoxicity Syndromes / Q000473:pathology* / Q000523:psychology*; D013406:Suicide, Attempted
chemical_list: D000931:Antidotes; D001152:Arsenicals; C020300:monomethylarsonic acid; D001151:Arsenic; D001663:Bilirubin